Adenoid cystic carcinoma (ACC) is usually an epithelial neoplasm of the salivary glands but can also occur in the lacrimal glands and the mucous glands of the respiratory tract, breasts and skin. Very rarely, it may affect the uterine cervix. We report here a case of a woman with postmenopausal bleeding for 7 months, who on physical examination presented with a vegetative and friable tumor lesion in the uterine cervix, measuring about 5 cm in diameter. The abdominal and pelvic computed tomography scans showed a hypodense and heterogeneous mass in the cervix and uterine isthmus. Histopathological examination and immunohistochemical assays confirmed the diagnosis of ACC. The different pathological aspects, therapeutic options and prognostic factors of ACC are discussed.
cases in the pediatric age group. Most individuals are diagnosed with the disease in the fourth through sixth decades of life. There is a slight female preponderance and no strong genetic or environmental risk factors have been identified.
The specific molecular abnormalities that underlie this disease process are unknown [1] .
Primary ACC of the cervix is uncommon, accounting for less than 1% of all cervical carcinomas, and still has an uncertain etiology [3] . In the absence of clinical trials or case reports in the literature, there are no recommended treatment guidelines for ACC of the cervix and patients are treated like any other carcinoma of the cervix. Even the prognosis is still unknown [4] .
Here, we report an extremely rare case of a patient who was diagnosed with cervical ACC. The patient had given her consent for the case report to be published.
Case Report
An 82-year-old white woman came to our hospital with continuous 
Discussion
ACC of the cervix is very rare and it usually occurs in postmenopausal women, [5]. Although tumor etiopathogenesis remains uncertain, Shi et al. [6] found 27 cases described in the literature of cervical ACC associated with cervical carcinomas, supporting the hypothesis that there is a common cellular origin and/or causative agent. Probably, the chronic HPV infection [6] .
In fact, some immunohistochemical evidence suggests that ACC develops from the multipotent basal cells of the cervical epithelium, which posterior squamous or glandular differentiation [7] .
Clinically, as reported in our case, this tumor is often manifested by conti- Histological examination of this type of tumor commonly reveals the presence of islets of pleomorphic basaloid cells in the medium of amorphous or mucinous eosinophilic hyaline material, forming adenoid structures, characterizing a cribriform pattern. In addition to this, other patterns can be described through examination, such as the tubular solid and undifferentiated pattern. The finding of areas of necrosis in the anatomopathological examination in our case, seems to be a common finding according to some authors [4] [7] . Lymphovascular invasion is also common in this type of tumor and was also detectable in our case. This common fact in this type of tumor can contribute to a worsening in prognosis [7] .
On the basis of morphology, pleomorphism, mitotic index and stromal hyalinization of ACC, it is possible to distinguish it from small cell carcinoma, basal adenoid carcinoma and nonkeratinized squamous cell carcinoma, considered to be its main differential diagnoses. In addition, immunohistochemical examination of ACC reveals diffuse positivity for CD 117, cytokeratin and CAM 5.2 [7] . In the case reported, these differential pathologic aspects could be noted as described previously.
Cervical ACC is characterized by an aggressive behavior, since it has a high predisposition for the invasion of adjacent organs, lymphatic vessels and perineural spaces and subsequently for hematogenous metastasis. There is evidence [8] . In fact, a preliminary review of 43 cases found overall survival for patients with stage I disease to be 56% at 3 -5 years. Even though some studies report a higher survival rate, this still appears to be considerably lower than in other types of stage I cervical tumors [9] . Thus, it seems logical that the treatment of ACC be instituted in a less conservative way than with other tumors of the uterine cervix.
Due to the rarity of this type of cervical cancer and the absence of prospective studies, no guidelines for treatment have been proposed so far. Thus, most of the patients are treated in a similar way as recommended for squamous cell cancer of the cervix. This aspect was considered in our patient and a radical treatment was performed. The management of the initial stages of the cervical ACC (stages I-II according to International Federation of Gynaecology and Obstetrics classification) involves surgical intervention, and radiotherapy is generally recommended as an adjuvant treatment. This recommendation is due to the fact that uterine cervix are considered radiosensitive tumors, and in previously reported cases, even in the early stages, better results were seen with adjuvant radiotherapy compared to surgical treatment alone [8] . The role of chemotherapy as adjunctive or primary treatment is still undefined, although in some case reports, chemotherapy has been indicated only for recurrent disease [7] . In our case, chemotherapy was used during radiotherapy. Considering that the main determinant of a patient's survival is metastasis, an aggressive local and systemic therapy is essential, considering local and distant recurrences. After surgery, we chose chemotherapy for our patient with weekly cisplatin during radiotherapy of 50 Gy in 25 fractions for 5 weeks and intracavitary brachytherapy at a dose of 7 Gy per fraction weekly for 3 weeks, which resulted in no recurrence during the 2-year follow-up. According to the literature, combined treatment appears to be necessary to obtain cure.
Conclusions
Our case report showed the characteristics of an infrequent tumor in an 82-year-old woman with a 6-cm mass in the uterine cervix, initially diagnosed as endometrial adenocarcinoma, on the basis of clinical and initial examinations.
The diagnosis changed completely after pathological examination and therefore, even patients with a compatible clinical setting, should be carefully investigated.
The use of radiotherapy and adjuvant chemotherapy is being evaluated in this type of tumor but since it has a poor prognosis, most of the oncologists ate using Open Journal of Obstetrics and Gynecology adjuvant therapy after surgery. Gynecologists should be familiar with the diagnosis of ACC and its treatment, so that treatment can be quickly initiated to limit damage to other organs and systems.
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